Skip to content
OpenCapital
Get started

Indivior Pharmaceuticals, Inc. INDV EBITDA margin

EBITDA margin at other companies

Alkermes logo
AlkermesALKS
14.8%-12.9pp
JAN
Janus Living JAN
-87.1%—

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%—

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Calculated from Indivior Pharmaceuticals, Inc. ’s reported figures.

ebitda/total revenue=26.5%

Based on trailing twelve months.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's EBITDA margin?
Indivior Pharmaceuticals, Inc. (INDV) reported EBITDA margin of 26.5% in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's EBITDA margin changed year-over-year?
Indivior Pharmaceuticals, Inc. 's EBITDA margin increased by 621.4% year-over-year, from 3.7% to 26.5%.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's EBITDA margin?
Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's EBITDA margin has grown at a 48.0% compound annual growth rate (CAGR), from -6.8% to 21.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.